Multiple Manufacturers

Dihydroergotamine Mesylate

Manufacturer:

Multiple Manufacturers

Dihydroergotamine Mesylate HCPCS:

J1110

HCPCS Code Descriptor:

Injection, dihydroergotamine mesylate, per 1 mg

Category:

J Code

Dihydroergotamine Mesylate NDCs:

00143-9273-10, 00574-0850-10, 61990-0411-02, 81284-0411-10, 00574-0850-05, 61990-0411-01, 81284-0411-05

Primary Type:

Neurology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

81284-0411-05

About Dihydroergotamine Mesylate:

Dihydroergotamine Mesylate is a Neurology drug manufactured by Apollo Pharmaceuticals and administered via the Injection route of administration. The J Code: J1110 is aligned to the drug Dihydroergotamine Mesylate.

ACCESS PRICING AND MORE BY REGISTERING

J1110 Added Date:

January 1, 1982

J1110 Effective Date:

January 1, 2019

J1110 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Dihydroergotamine Mesylate billing and coding information.
Dihydroergotamine Mesylate patient assistance information can be found through Impel Pharmaceuticals Patient Assistance Program at the URL: https://trudhesa.com/getting-trudhesa/
Dihydroergotamine Mesylate prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for Dihydroergotamine Mesylate. Please check back in a few weeks.